Overview
This North Carolina legislation establishes a comprehensive regulatory framework governing transactions involving hospital entities, with the primary objective of protecting patients, healthcare professionals, and the public interest when hospitals are acquired or undergo significant ownership changes. The bill creates a structured review and approval process administered jointly by the State Auditor, Attorney General, and State Treasurer, requiring meaningful transparency, public participation, and rigorous scrutiny of proposed hospital transactions before they can proceed. Beyond transaction oversight, the bill strengthens financial assistance policy protections for patients, expands whistleblower protections for healthcare professionals, and creates enforcement mechanisms including civil penalties to ensure compliance. The legislation reflects a policy determination that hospital transactions carry unique public interest implications that distinguish them from ordinary commercial transactions, warranting heightened state oversight to preserve access to affordable, quality healthcare services across North Carolina communities.
Key Points
- Establishes a tri-agency review process (State Auditor, Attorney General, State Treasurer) for hospital transactions
- Mandates transparency and public notice requirements for proposed hospital acquisitions
- Protects patients' access to financial assistance policies during and after ownership transitions
- Creates whistleblower protections for healthcare professionals reporting violations
- Authorizes civil penalties up to $1,000,000 for violations
- Prevents hospital licensing for entities that violate the transaction review requirements
Core Provisions
The bill's most significant structural change is the creation of a mandatory pre-transaction review process under G.S. 131E-214.24 through G.S. 131E-214.40. Hospital entities and acquiring entities must provide written notice to the State Auditor, Attorney General, and State Treasurer before completing any covered transaction, triggering a 90-day review period that begins upon receipt of a complete notice meeting all statutory requirements. The review period may be extended by up to an additional 30 days when necessary, giving the tri-agency panel a maximum of 120 days to evaluate a proposed transaction. Upon completing their review, the agencies may approve the transaction, approve it subject to modifications, or disapprove it entirely if they determine it would have a significant and deleterious effect on healthcare in the State [§131E-214.38]. The notice requirements under §131E-214.24 are extensive. The acquiring entity must provide patients who previously benefited from the hospital's financial assistance policy with written notice that includes a description of the new financial assistance policy, a detailed summary of the proposed transaction, copies of all transactional and collateral agreements, the names of all parties, the nature of the transaction, the anticipated consideration to be paid, a toll-free telephone number for patient inquiries, and a link to a public webpage displaying the new policy and required patient forms. The acquiring entity must also educate all affiliated physicians on the new financial assistance policy. Additionally, acquiring entities must provide 120 days' notice before implementing changes to financial assistance policies, ensuring patients have adequate time to understand and respond to coverage changes. The criteria the tri-agency panel must consider under §131E-214.32 are comprehensive and include whether the fair market value of transferred assets has been manipulated, the impact on cost, availability, accessibility, and quality of healthcare services, whether sufficient safeguards ensure continued access to affordable care, the transaction's impact on medical education and research, whether the transaction would result in a breach of fiduciary duty by the hospital entity's governing body, whether due diligence was exercised, whether the transaction would result in private inurement to any person, and whether any foundation established to hold transaction proceeds would be broadly based in the community. The bill also amends Article 52 of Chapter 66 (G.S. 66-515 et seq.) to protect healthcare professionals from nondisclosure agreements and non-compete clauses that would prevent them from reporting violations, and creates explicit whistleblower protections under G.S. 95-28.1B against retaliation for reporting violations of medical staff bylaws or making comments concerning patient care. Civil penalties range up to $50,000 for standard violations and up to $1,000,000 for more serious infractions, with acquiring entities also subject to annual compliance reporting requirements.
Legal References
- G.S. 131E-214.24 (Notice of proposed transaction)
- G.S. 131E-214.26 (Timeline and process for decision)
- G.S. 131E-214.30 (Public hearing requirements)
- G.S. 131E-214.32 (Required considerations by reviewing agencies)
- G.S. 131E-214.36 (Review fees)
- G.S. 131E-214.38 (Authority to object)
- G.S. 131E-214.40 (Civil penalties and annual reporting)
- G.S. 66-515 (Definitions for Article 52)
- G.S. 66-516 (Healthcare professional protections)
- G.S. 66-517 (Non-compete and nondisclosure restrictions)
- G.S. 95-28.1B (Healthcare professional whistleblower protection)
Implementation
Implementation responsibility is distributed among three state agencies — the State Auditor, Attorney General, and State Treasurer — who must act jointly throughout the review process. These agencies are authorized to adopt rules specifying the required contents of written notices and the manner in which they must be provided, giving them rulemaking authority to operationalize the statutory requirements. The agencies may also contract with, consult, and receive advice from any state or federal agency to assist in reviewing proposed transactions, and are explicitly exempted from the standard procurement requirements of Article 3 of Chapter 143 of the General Statutes when entering into such contracts, enabling faster and more flexible engagement of expert consultants. The Department of Health and Human Services plays a supporting role by preparing reports on the anticipated effects of proposed transactions for the tri-agency panel's consideration. DHHS is also given enforcement authority through its licensing function: it shall not issue a new or renewal hospital operating license to any hospital that is a party to a transaction entered into in violation of this Article, creating a powerful compliance incentive. The North Carolina Board of Medicine and the North Carolina Commission are referenced as additional stakeholders in the implementation ecosystem. Funding for the review process is borne primarily by the transacting parties. The acquiring entity must pay a fee of up to $50,000 to cover the tri-agency panel's review costs, and must also pay for the DHHS report. All costs associated with public hearings are borne by the parties to the proposed transaction. The acquiring entity retains the right to contest fees it believes are unreasonable by seeking a court order limiting its liability. Civil penalty proceeds are remitted to the Civil Penalty and Forfeiture Fund in accordance with G.S. 115C-457.2. Annual compliance reports must be submitted by acquiring entities to the tri-agency panel following transaction completion, creating an ongoing post-transaction oversight mechanism. Public hearings must be conducted at convenient times and locations in counties where the hospital entity exists, with at least seven days' prior written notice to the agencies and meaningful opportunities for public questions, answers, and comments.
Legal References
- G.S. 131E-214.24 (Notice requirements and rulemaking authority)
- G.S. 131E-214.26 (Review timeline and agency contracting authority)
- G.S. 131E-214.30 (Public hearing procedures)
- G.S. 131E-214.36 (Fee authority and cost recovery)
- G.S. 131E-214.40 (Annual reporting and civil penalties)
- G.S. 115C-457.2 (Civil Penalty and Forfeiture Fund)
- Article 3 of Chapter 143, General Statutes (procurement exemption)
- Article 5 of Chapter 131E (hospital licensing)
Impact
The bill's most direct beneficiaries are patients of hospital entities subject to acquisition, particularly low-income patients who rely on financial assistance policies for access to care. The mandatory notice requirements, 120-day advance notice for policy changes, toll-free inquiry lines, and public webpage disclosures ensure that vulnerable patients are not blindsided by coverage changes following a hospital transaction. The requirement that acquiring entities educate affiliated physicians on new financial assistance policies further ensures that the patient-facing workforce can guide patients through coverage transitions. Healthcare professionals benefit substantially from the expanded whistleblower protections and the restrictions on nondisclosure agreements and non-compete clauses that could otherwise silence concerns about patient care quality or regulatory violations. These protections address a recognized power imbalance between employed physicians and large acquiring entities, particularly in markets where hospital consolidation has reduced physician employment alternatives. The administrative burden on hospital entities and acquiring entities is significant. The comprehensive notice requirements, mandatory public hearings, fee obligations, DHHS report costs, and annual compliance reporting create substantial transaction costs that will factor into acquisition economics. The 90-to-120-day review timeline adds meaningful delay to transaction completion, which may affect deal certainty and financing arrangements. Smaller acquiring entities may find the fee and compliance structure disproportionately burdensome relative to larger health systems with dedicated regulatory affairs infrastructure. For the state, the bill creates new administrative responsibilities across three agencies and DHHS without specifying dedicated appropriations, relying instead on fee recovery from transacting parties. The expected outcome is a more transparent hospital transaction market with stronger community accountability, reduced risk of post-acquisition deterioration in healthcare access, and a deterrent effect against transactions that would harm public health. There are no sunset provisions identified in the analyzed sections, suggesting these requirements are intended as permanent regulatory infrastructure. Key effective dates are July 1, 2026 for certain provisions and January 1, 2027 for others.
Legal Framework
The bill operates within North Carolina's established statutory authority over hospital licensing and healthcare regulation under Chapter 131E of the General Statutes, extending that framework to encompass transaction oversight. The tri-agency review structure — combining the State Auditor, Attorney General, and State Treasurer — is an unusual governance arrangement that distributes authority across independently elected constitutional officers, likely designed to prevent any single official from controlling outcomes and to bring complementary expertise (financial auditing, legal enforcement, and fiscal oversight) to bear on complex transactions. The Attorney General's participation is particularly significant from a legal framework perspective, as the Attorney General has independent constitutional and statutory authority over charitable assets and nonprofit corporations in North Carolina. Many hospital entities are organized as nonprofit corporations, and transactions involving the transfer of nonprofit assets implicate the Attorney General's cy pres and parens patriae authority. The bill codifies and structures this authority within a defined procedural framework rather than leaving it to ad hoc enforcement. The bill's authority to block hospital licensing for non-compliant transactions under Article 5 of Chapter 131E represents a direct exercise of the state's police power over healthcare facilities, which has well-established constitutional grounding. The civil penalty structure, with penalties up to $1,000,000, must satisfy due process requirements, and the bill preserves judicial review by allowing acquiring entities to seek court orders contesting fees and, implicitly, other agency determinations. The exemption from standard procurement requirements (Article 3 of Chapter 143) when the agencies contract for expert assistance is a targeted statutory carve-out that facilitates flexible and timely review without subjecting the process to procurement delays. The whistleblower protections under G.S. 95-28.1B and the restrictions on non-compete and nondisclosure agreements under G.S. 66-516 and 66-517 operate within North Carolina's existing employment law framework, expanding protections that already exist for other categories of workers.
Legal References
- Chapter 131E, North Carolina General Statutes (hospital regulation)
- G.S. 131E-214.24 through G.S. 131E-214.40 (transaction review framework)
- Article 3 of Chapter 143, General Statutes (procurement law, exempted)
- Article 5 of Chapter 131E (hospital licensing)
- G.S. 115C-457.2 (Civil Penalty and Forfeiture Fund)
- G.S. 95-28.1B (whistleblower protection)
- G.S. 66-515, G.S. 66-516, G.S. 66-517 (Article 52, healthcare professional protections)
Critical Issues
The tri-agency governance structure, while designed to distribute power and bring multiple perspectives to bear, creates significant coordination challenges. The State Auditor, Attorney General, and State Treasurer are independently elected officials who may hold different policy views, face different political pressures, and operate with different institutional priorities. The bill does not specify how disagreements among the three officials are resolved, whether unanimous agreement is required to block a transaction, or what happens when the agencies reach conflicting conclusions. This ambiguity creates legal uncertainty for transacting parties and potential for inconsistent outcomes. The 90-to-120-day review timeline, while reasonable from a public interest standpoint, introduces deal uncertainty that could deter beneficial transactions or drive hospital entities toward alternative transaction structures designed to avoid triggering the review requirements. The definition of covered transactions and the scope of the term 'hospital entity' under G.S. 131E-6 and G.S. 131E-16 will be critical in determining whether parties can structure transactions to fall outside the review framework, and litigation over these definitional boundaries is foreseeable. The cost-shifting mechanism — requiring acquiring entities to pay review fees, DHHS report costs, and public hearing expenses — while fiscally prudent for the state, may create perverse incentives. Agencies that recover their costs from the parties they regulate may face questions about institutional independence and the objectivity of their review. The acquiring entity's right to seek judicial relief from fees provides some check on this dynamic but adds litigation risk and cost to the transaction process. The civil penalty range of up to $1,000,000 is substantial and raises due process questions about the criteria for imposing maximum penalties versus lower amounts. The bill does not specify a graduated penalty schedule or the factors that distinguish a $50,000 penalty from a $1,000,000 penalty, leaving significant discretion to the agencies and creating potential for arbitrary or inconsistent enforcement. Finally, the requirement that DHHS deny licensing to hospitals involved in non-compliant transactions is a powerful sanction that could effectively force hospital closure, raising concerns about patient access to care in communities where the non-compliant hospital is the primary or sole provider — an outcome that would directly contradict the bill's stated goal of protecting healthcare access.
Legal References
- G.S. 131E-214.26 (review timeline and agency authority)
- G.S. 131E-214.36 (fee authority and judicial review of fees)
- G.S. 131E-214.38 (authority to object to transactions)
- G.S. 131E-214.40 (civil penalty structure)
- G.S. 131E-6 (hospital definitions)
- G.S. 131E-16 (hospital entity definitions)
- Article 5 of Chapter 131E (licensing denial for non-compliant transactions)